Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: A pilot trial on five-factor prediction of antidepressant response

Neuroscience Letters

Volumn 563, Issue , 2014, Pages 144-148

  McGirr, Alexander ^a   Van den Eynde, Frederique ^b   Chachamovich, Eduardo ^b   Fleck, Marcelo P A ^b   Berlim, Marcelo T ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Deep transcranial magnetic stimulation; Five factor personality; Major depression; Personality; Transcranial magnetic stimulation

Indexed keywords

ADULT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEEP REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; EXTRAVERSION; FEMALE; HAMILTON SCALE; HUMAN; MALE; NEUROSIS; PERSONALITY; PILOT STUDY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SENSITIVITY AND SPECIFICITY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE;

DEEP TRANSCRANIAL MAGNETIC STIMULATION; FIVE-FACTOR PERSONALITY; MAJOR DEPRESSION; PERSONALITY; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; EXTRAVERSION (PSYCHOLOGY); FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY; PERSONALITY ASSESSMENT; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84894325112     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.01.037     Document Type: Article

References (39)

1. Agosti V., McGrath P.J. Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression. J. Affect. Disord. 2002, 71:113-120.
2. Benet-Martinez V., John O.P. Los cinco grandes across cultures and ethnic groups: multitrait multimethod analyses of the Big Five in Spanish and English. J. Pers. Soc. Psychol. 1998, 75:729-750.
3. Berlim M.T., McGirr A., Beaulieu M.M., Van Den Eynde F., Turecki G. Are neuroticism and extraversion associated with the antidepressant effects of repetitive transcranial magnetic stimulation (rTMS)? An exploratory 4-week trial. Neurosci. Lett. 2013, 534:306-310.
4. Berlim M.T., Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can. J. Psychiatry 2007, 52:46-54.
5. Berlim M.T., Van den Eynde F., Jeff Daskalakis Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology 2013, 38:543-551.
6. Berlim M.T., Van den Eynde F., Perdomo S.T., Chachamovich E., Zangen A., Turecki G. Augmenting antidepressants with deep transcranial magnetic stimulation in highly treatment-resistant major depression 2014, submitted.
7. Berlim M.T., Van den Eynde F., Tovar-Perdomo S., Daskalakis Z.J. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol. Med. 2013, 18:1-15.
8. Clark L.A., Watson D., Temperament An organizing paradigm for trait psychology. Handbook of Personality: Theory and Research 2008, 265-286. Guilford Press, New York. O.P. John, R.W. Robins, L.A. Pervin (Eds.).
9. Couturier J.L. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J. Psychiatry Neurosci. 2005, 30:83-90.
10. Daskalakis Z.J., Levinson A.J., Fitzgerald P.B. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can. J. Psychiatry 2008, 53:555-566.
11. DeYoung C.G., Hirsh J.B., Shane M.S., Papademetris X., Rajeevan N., Gray J.R. Testing predictions from personality neuroscience. Brain structure and the Big Five. Psychol. Sci. 2010, 21:820-828.
12. Dolan R.J., Bench C.J., Brown R.G., Scott L.C., Friston K.J., Frackowiak R.S. Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J. Neurol. Neurosurg. Psychiatry 1992, 55:768-773.
13. Dunner D.L., Rush A.J., Russell J.M., Burke M., Woodard S., Wingard P., Allen J. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J. Clin. Psychiatry 2006, 67:688-695.
14. Fekadu A., Wooderson S.C., Markopoulo K., Donaldson C., Papadopoulos A., Cleare A.J. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. J. Affect. Disord. 2009, 116:4-11.
15. Fitzgerald P.B. Repetitive transcranial magnetic stimulation treatment for depression: lots of promise but still lots of questions. Brain Stimul. 2010, 2:185-187.
16. Fournier J.C., DeRubeis R.J., Hollon S.D., Dimidjian S., Amsterdam J.D., Shelton R.C., Fawcett J. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010, 303:47-53.
17. George M.S., Aston-Jones G. Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology 2010, 35:301-316.
18. George M.S., Padberg F., Schlaepfer T.E., O'Reardon J.P., Fitzgerald P.B., Nahas Z.H., Marcolin M.A. Controversy: repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treating psychiatric diseases (depression, mania, schizophrenia, obsessive-complusive disorder, panic, posttraumatic stress disorder). Brain Stimul. 2009, 2:14-21.
19. George M.S., Wassermann E.M. Rapid-rate transcranial magnetic stimulation and ECT. Convulsive Ther. 1994, 10:255-258. 251-254 discussion.
20. Hamilton Rating Scale for Depression (Ham-D) 2000, American Psychiatric Publishing, Washington, DC. M. Hamilton (Ed.).
21. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
22. Hoppenbrouwers S.S., Farzan F., Barr M.S., Voineskos A.N., Schutter D.J., Fitzgerald P.B., Daskalakis Z.J. Personality goes a long a way: an interhemispheric connectivity study. Front Psychiatry 2010, 1:140.
23. Karsten J., Penninx B.W., Riese H., Ormel J., Nolen W.A., Hartman C.A. The state effect of depressive and anxiety disorders on Big Five personality traits. J. Psychiatr. Res. 2012, 46:644-650.
24. Lejuez C.W., Hopko D.R., Hopko S.D. A brief behavioral activation treatment for depression. Treatment manual. Behav. Modif. 2001, 25:255-286.
25. Levkovitz Y., Harel E.V., Zangen A. Deep transcranial magnetic stimulation over the left prefrontal cortex for major depressive disorder: results from a large multicentre randomized controlled trial 2014, submitted.
26. Levkovitz Y., Harel E.V., Roth Y., Braw Y., Most D., Katz L.N., Sheer A., Gersner R., Zangen A. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimul. 2010, 4:188-200.
27. Martin J.L., Barbanoj M.J., Schlaepfer T.E., Thompson E., Perez V., Kulisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br. J. Psychiatry 2003, 182:480-491.
28. Ridding M.C., Rothwell J.C. Is there a future for therapeutic use of transcranial magnetic stimulation?. Nat. Rev. Neurosci. 2007, 8:559-567.
29. Rosa M.A., Lisanby S.H. Somatic treatments for mood disorders. Neuropsychopharmacology 2012, 37:102-116.
30. Roth Y., Zangen A., Hallett M. A coil design for transcranial magnetic stimulation of deep brain regions. J. Clin. Neurophysiol. 2002, 19:361-370.
31. Rush A.J., Trivedi M.H., Ibrahim H.M., Carmody T.J., Arnow B., Klein D.N., Markowitz J.C., Ninan P.T., Kornstein S., Manber R., Thase M.E., Kocsis J.H., Keller M.B. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol. Psychiatry 2003, 54:573-583.
32. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., Niederehe G., Thase M.E., Lavori P.W., Lebowitz B.D., McGrath P.J., Rosenbaum J.F., Sackeim H.A., Kupfer D.J., Luther J., Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 2006, 163:1905-1917.
33. Sackeim H.A. The definition and meaning of treatment-resistant depression. J. Clin. Psychiatry 2001, 62(16):10-17.
34. Sampaio A., Soares J.M., Coutinho J., Sousa N., Goncalves O.F. The Big Five default brain: functional evidence. Brain Struct. Funct. 2013, 2013:24.
35. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(20):22-33. quiz 34-57.
36. Spinhoven P., Elzinga B., Roelofs K., Hovens J.G., van Oppen P., Zitman F.G., Penninx B.W. The effects of neuroticism, extraversion, and positive and negative life events on a one-year course of depressive symptoms in euthymic previously depressed patients versus healthy controls. J. Nerv. Ment. Dis. 2011, 199:684-689.
37. Spronk D., Arns M., Bootsma A., van Ruth R., Fitzgerald P.B. Long-term effects of left frontal rTMS on EEG and ERPs in patients with depression. Clin. EEG Neurosci. 2008, 39:118-124.
38. Tang T.Z., DeRubeis R.J., Hollon S.D., Amsterdam J., Shelton R., Schalet B. Personality change during depression treatment: a placebo-controlled trial. Arch. Gen. Psychiatry 2009, 66:1322-1330.
39. Widiger T.A., Lowe J.R. Five-factor model assessment of personality disorder. J. Pers. Assess. 2007, 89:16-29.